1 and 2A were created using BioRender.com
Effectiveness: In a study of 2,539 adults with obesity or overweight plus at least one weight-related medical condition (excluding diabetes), the average weight loss at 72 weeks was 15% with 5 mg weekly doses of tirzepatide, 19.5% with 10 mg doses, and almost 21% with 15 mg doses
Many Sculptique protocols use 23 injections per week rather than daily, particularly for skin and maintenance goals
Once you reach your weight-management goals, your clinician may advise continuing treatment to help maintain your weight loss, as weight tends to be regained after stopping
Injection site irritation (5%): Standard for any subcutaneous peptide
Wegovy and Saxenda can help kickstart the process, but your daily efforts will determine how effective and lasting your weight loss journey will be